Company / R&D per Share
Nuvation Bio Inc. R&D per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.34
FY2025
5-year range
$0.34 / $405.20
FY2021-FY2025
Trend
-24.7%
vs FY2024
Sector context
#183 of 208
Health Care
What the data says
Nuvation Bio Inc.'s r&d per share of $0.34 is lower than 88% of companies in the Health Care sector (FY2025). R&D per Share has declined for 3 consecutive years, from $405.20 in FY2022 to $0.34 in FY2025.
Based on SEC 10-K filings.
0.34 in FY2025 with a 5-year CAGR of +0.4%.
Declined from $325.70 to $0.34 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -90.6%
- 5-Year CAGR
- +0.4%
- 10-Year CAGR
- -
Sector benchmark
Bottom 12% in Health CareTop 88% of 208This company $0.34 Sector average $28.82
▼
-98.8% below sector average
Key checks
Key Insights
- Nuvation Bio Inc.'s r&d per share has declined for 3 consecutive years.
- In FY2025, r&d per share decreased 24.7% year-over-year.
- Ranks #183 out of 208 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -1.56 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.34 | -24.7% |
| FY2024 | $0.45 | -99.9% |
| FY2023 | $325.70 | -19.6% |
| FY2022 | $405.20 | +16.1% |
| FY2021 | $348.87 | +104262.7% |
| FY2020 | $0.33 | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026